Skip to content

To evaluate the skin health of Kapiva skin foods glow mix ayurvedic powder.

An open label, prospective, single arm study to evaluate the Skin health enhancing ability of Kapiva Skin foods Glow Mix- An ayurvedic powder-based drink in healthy adult female face skin.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041729
Enrollment
15
Registered
2022-04-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kapiva Adret Retail Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Female adult subjects in general good health & age the group of 30 to 50 Years. 2. Subject must not have used any anti-aging cream prior to study enrolment and intend to use during the study 3. Subject who agrees not to use any other product/treatment/home remedy/soap bar on their face during the study period other than the test product. 4. Subject with Fitzpatrick skin types III to V. 5. Subjects having visible fine lines and wrinkles in periorbital area like Crowââ?¬•s feet-under eye & forehead as assessed by dermatologist. 6. Subjects having skin aging concerns as assessed by dermatologist 7. Subjects not having hair style which covers almost the entire forehead. 8. Subject free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face.

Exclusion criteria

Exclusion criteria: 1.Subject if using any anti-aging cream prior to study enrolment and intend to use during the study. 2. Subject with any other signs of significant local irritation or skin disease. 3. subjects who experience nausea or vomiting due to the flavor or product will be excluded from the study 4. Subject currently taking any medication including food supplements, which the Investigator believes may influence the interpretation of the data. 5. Subjects showing abnormal levels in blood test parameters. (Subjects having abnormal values but are clinically fit to participate in the trial would be enrolled in the study at Principal Investigatorââ?¬•s Discretion). 6. Subject having chronic illness or had major surgery in the last year. 7. Subjects undergoing any treatment of any skin condition on their face/forearm/any. 8. Subjects not willing to discontinue other topical facial products.

Design outcomes

Primary

MeasureTime frame
To assess the skin health enhancing attributes in healthy adult female face by a. evaluation of moisture balance using corneometer b. Evaluation of chemical and hormonal reactions in skin by screening for acne. c. Screening for the skin firmness by evaluating the muscle mass in face, wrinkles. Timepoint: Assessment will be done at Day- 1, Day 7, Day-14, Day-21, and day 30 (End of study) as compared to the baseline

Secondary

MeasureTime frame
To screen for efficacy of glow mix to prevent /reduce hyperpigmentation.Timepoint: Assessment will be done at Day- 1, Day 7, Day-14, Day-21, and day 30 (End of study) as compared to the baseline

Countries

India

Contacts

Public ContactMeena Dalal

Trial Guna Pvt Ltd

sandyalva78@yahoo.co.in9964819720

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026